Leptin as Clinical Target

E-ISSN： 2212-2710|3|3|160-166

ISSN： 1872-213X

Source： Recent Patents on Inflammation & Allergy Drug Discovery, Vol.3, Iss.3, 2009-11, pp. : 160-166

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Patents on the Identification and Clinical Application of microRNAs and Target Genes

Recent Patents on DNA & Gene Sequences, Vol. 1, Iss. 2, 2007-06 ,pp. : 116-124

Bentham Science Publishers

Access to resources Recommend Favorite

Advancement in Obesity Management: Leptin and Adiponectin Patents

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 2, Iss. 3, 2008-11 ,pp. : 200-203

Bentham Science Publishers

Access to resources Recommend Favorite

Economic selection of optimal target values

By Rahim M.A. Shaibu A.-B.

Process Control and Quality, Vol. 11, Iss. 5, 2000-01 ,pp. : 369-381

VSP

Access to resources Recommend Favorite

HMGB-1 as a Target for Inflammation Controlling

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 6, Iss. 3, 2012-09 ,pp. : 201-209

Bentham Science Publishers

Access to resources Recommend Favorite

HDL - Cholesterol: The New Target for Treatment

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 4, Iss. 2, 2010-06 ,pp. : 153-160

Bentham Science Publishers

Access to resources Recommend Favorite